Additionally, high expression of HMGB2 correlates with metastasis and, in some cases, with a decrease in sensitivity to certain anticancer drugs, such as cisplatin [98], leading to a resistance of cancer cells to chemotherapy and poor prognosis. The gene discussed is HMGB2; the disease is cancer.